TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3619710

Group type: EXPERIMENTAL
Intervention: Long-acting propranolol (160 mg/d)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Primidone (250 mg at night)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Clonazepam (4 mg/d)
Number of subjects: 10
Study: 30075490

Group type: EXPERIMENTAL
Intervention: Standard care plus intervention (adherence education, reinforcement and monitoring) in HIV group
Number of subjects: 238

Group type: COMPARATOR
Intervention: Local standard care (controls) in HIV group
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Standard care plus intervention (adherence education, reinforcement and monitoring) in TBM group
Number of subjects: 238

Group type: COMPARATOR
Intervention: Local standard care (controls) in TBM group
Number of subjects: 238
Study: 27145035

Group type: EXPERIMENTAL
Intervention: 72 hour stroke care bundle (intervention group)
Number of subjects: 127
Study: 25914482

Group type: EXPERIMENTAL
Intervention: Visual distraction (silent movie using a head-mounted display)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (only wearing the display)
Number of subjects: 60
Study: 23832723

Group type: EXPERIMENTAL
Intervention: Conventional treatment plus Simvastatin (combination group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal group (healthy persons)
Number of subjects: 80
Study: 20494267

Group type: EXPERIMENTAL
Intervention: Atomoxetine hydrochloride + MI/CBT
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo + MI/CBT
Number of subjects: 70
Study: 18208570

Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (90 or 180 mug/week)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: interferon alfa-2a (3 million units three times weekly)
Number of subjects: 184

Group type: COMPARATOR
Intervention: nonresponders
Number of subjects: 184
Study: 15116906

Group type: EXPERIMENTAL
Intervention: Warm vertical compaction of gutta-percha (G2)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Thermafil system (G3)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lateral condensation (G1)
Number of subjects: 32
Study: 11842899

Group type: EXPERIMENTAL
Intervention: Flat-plane stabilization occlusal device
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Anatomic occlusal device
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 11
Study: 9669005

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Total Intravenous Anaesthesia (TIVA)
Number of subjects: 80
Study: 8002087

Group type: EXPERIMENTAL
Intervention: Ceftriaxone and teicoplanin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Ceftazidime and teicoplanin
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Ceftriaxone and teicoplanin with netilmicin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Ceftazidime and teicoplanin with netilmicin
Number of subjects: 97
Study: 3353874

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen for 10 minutes before exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Compressed air for 10 minutes before exercise
Number of subjects: 20
Study: 31197340

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (tPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endovascular thrombectomy (MT)
Number of subjects: 0
Study: 28364678

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) and individualized rehabilitation
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no NMES)
Number of subjects: 128
Study: 25725564

Group type: EXPERIMENTAL
Intervention: Intratympanic steroid (ITS) initial treatment (ITSi)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 70

Group type: COMPARATOR
Intervention: Systemic steroid treatment
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intratympanic salvage treatment (ITSs)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: All groups (including ITSi, combined, systemic, and ITSs)
Number of subjects: 70
Study: 24237360

Group type: EXPERIMENTAL
Intervention: ED group (experienced dentists)
Number of subjects: 74
Study: 21584345

Group type: EXPERIMENTAL
Intervention: Behavioral Assessment of the Dysexecutive Syndrome
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Modified Six Elements - adapted (general index)
Number of subjects: 41
Study: 19574328

Group type: EXPERIMENTAL
Intervention: Nonpharmacological interventions
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: General medical journals
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Trials published after 2000
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Overall trial quality
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: High impact factor journals
Number of subjects: 344
Study: 16847412

Group type: EXPERIMENTAL
Intervention: Uridine-enriched food supplement NucleomaxX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NucleomaxX supplementation
Number of subjects: 0
Study: 14657844

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical calcineurin inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy and early intervention
Number of subjects: 0
Study: 11464618

Group type: EXPERIMENTAL
Intervention: Treatment for Helicobacter pylori infection
Number of subjects: 0
Study: 9460034

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional neuroleptics
Number of subjects: 20
Study: 8455665

Group type: EXPERIMENTAL
Intervention: Ondansetron (n = 85)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Dexamethasone plus metoclopramide (n = 80)
Number of subjects: 165
Study: 3940358

Group type: EXPERIMENTAL
Intervention: Orotracheal intubation (OT)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Nasotracheal intubation (NT)
Number of subjects: 91
Study: 30547305

Group type: EXPERIMENTAL
Intervention: High-flexion TKA implant
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard TKA implant
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both implant designs
Number of subjects: 103
Study: 29763676

Group type: EXPERIMENTAL
Intervention: Real dual-tDCS (anodal over the lesioned hemisphere, cathodal over the non-lesioned hemisphere) at 2-mA intensity for 20 minutes followed by conventional physical therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham dual-tDCS followed by conventional physical therapy
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Real dual-tDCS
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Real dual-tDCS and conventional physical therapy
Number of subjects: 19
Study: 26577796

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 2739

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2739
Study: 24662947

Group type: EXPERIMENTAL
Intervention: E10A plus chemotherapy (cisplatin and paclitaxel)
Number of subjects: 136
Study: 22664749

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 600 mg
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 1200 mg
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 1800 mg
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 2400 mg
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 20398258

Group type: EXPERIMENTAL
Intervention: New colour-coded blood pressure diary
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conventional blood pressure diary
Number of subjects: 138
Study: 17549429

Group type: EXPERIMENTAL
Intervention: Rehabilitation (REH)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Medication (MED) (oxybutynin ER)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both REH and MED
Number of subjects: 44
Study: 15766372

Group type: EXPERIMENTAL
Intervention: Microsurgical approach
Number of subjects: 10

Group type: COMPARATOR
Intervention: Macrosurgical approach
Number of subjects: 10
Study: 12003160

Group type: EXPERIMENTAL
Intervention: Melatonin (5mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9797978

Group type: EXPERIMENTAL
Intervention: Experimental treatment combining two therapies
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo treatment designed to mimic experimental treatment
Number of subjects: 38
Study: 8106774

Group type: EXPERIMENTAL
Intervention: GenHevac B vaccine (G), 20 micrograms/dose
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hevac B vaccine (H), 5 micrograms/dose
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: GenHevac B vaccine (G), after booster at month 12
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hevac B vaccine (H), after booster at month 12
Number of subjects: 120
Study: 2698453

Group type: EXPERIMENTAL
Intervention: 0.5 mg fluspirilene
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 1.0 mg fluspirilene
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 1.5 mg fluspirilene
Number of subjects: 106
Study: 4549500

Group type: EXPERIMENTAL
Intervention: Monovalent acetone‐inactivated typhoid vaccine by jet injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat‐killed TAB by jet injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional syringe injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both vaccines (monovalent acetone‐inactivated typhoid vaccine and heat‐killed TAB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second jet injection 5 weeks after the first
Number of subjects: 0
Study: 31705728

Group type: EXPERIMENTAL
Intervention: Tasuki-style posture supporter
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waiting-list
Number of subjects: 50
Study: 31431378

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (NCRT) plus surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study: 29231496

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with auricular point sticking therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medication group (20 mg paroxetine hydrochloride once a day for 8 weeks)
Number of subjects: 60
Study: 24590412

Group type: EXPERIMENTAL
Intervention: Family-centered, school-based intervention including a 13-week behavioral parenting intervention and concurrent group for children.
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Family-centered, school-based intervention for highest-risk families.
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Family-centered, school-based intervention for boys at high risk for problems based on baseline behavioral dysregulation.
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Pre-kindergarten education as usual (control condition).
Number of subjects: 1050
Study: 23359575

Group type: EXPERIMENTAL
Intervention: Early Start program
Number of subjects: 443

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 443
Study: 21365053

Group type: EXPERIMENTAL
Intervention: Prosthetic abutments with a Morse taper connection and a platform switch (test group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional abutments with an internal connection and a matching diameter (control group)
Number of subjects: 40
Study: 18758872

Group type: EXPERIMENTAL
Intervention: Transorally introduced circular stapler (SurgASSIST)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Transabdominal introduced circular stapler (CEEA)
Number of subjects: 20
Study: 16864708

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus GG and Bifidobacterium lactis Bb-12)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 12640530

Group type: EXPERIMENTAL
Intervention: 48-week group (6 MU of natural IFN-alpha by intramuscular injection three times weekly for 24 weeks)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 72-week group (6 MU of natural IFN-alpha by intramuscular injection three times weekly for 48 weeks)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 48-week group
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 72-week group
Number of subjects: 51
Study: 16862613

Group type: EXPERIMENTAL
Intervention: Lightweight polypropylene mesh
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard polypropylene mesh
Number of subjects: 600
Study: 10553857

Group type: EXPERIMENTAL
Intervention: Succinylcholine (1.0 mg/kg)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Mivacurium (0.20 mg/kg)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Rocuronium (0.6 mg/kg)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Atracurium (0.5 mg/kg)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.08 mg/kg)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Overall intubating conditions (all groups)
Number of subjects: 172
Study: 8916815

Group type: EXPERIMENTAL
Intervention: Desflurane (1.0 MAC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isoflurane (1.0 MAC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Desflurane (0.5 MAC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isoflurane (0.5 MAC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol (control group)
Number of subjects: 30
Study: 1677901

Group type: EXPERIMENTAL
Intervention: 120 mg terfenadine once daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: 60 mg terfenadine twice daily
Number of subjects: 30
Study: 6349950

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 103

Group type: COMPARATOR
Intervention: Metronidazole and Gentamicin
Number of subjects: 103
Study: 28382883

Group type: EXPERIMENTAL
Intervention: Hatha yoga classes
Number of subjects: 122

Group type: COMPARATOR
Intervention: Health education classes (HLW)
Number of subjects: 122
Study: 27332391

Group type: EXPERIMENTAL
Intervention: Daily teleconsultation for one week between hospital-based telenurses and patients with severe COPD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study: 25058084

Group type: COMPARATOR
Intervention: Digital mammography
Number of subjects: 454850

Group type: EXPERIMENTAL
Intervention: Digital mammography + tomosynthesis
Number of subjects: 454850
Study: 22336194

Group type: EXPERIMENTAL
Intervention: Preventative physiotherapy program, carried out twice a day for three weeks (week 34, 35, 36 postmenstrual age).
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard follow-up care (control group).
Number of subjects: 150
Study: 19171294

Group type: EXPERIMENTAL
Intervention: Diabetes Outpatient Intensive Management Program (DOIMP)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional diabetes education
Number of subjects: 49
Study: 17239873

Group type: EXPERIMENTAL
Intervention: Operative resectoscopy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bipolar electrode excision
Number of subjects: 100
Study: 15645313

Group type: EXPERIMENTAL
Intervention: Radiation exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New data sets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Historic data sets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk estimates at low exposures
Number of subjects: 0
Study: 12221462

Group type: EXPERIMENTAL
Intervention: Postoperative local irradiation
Number of subjects: 44

Group type: COMPARATOR
Intervention: No local graft irradiation (Control)
Number of subjects: 44
Study: 9436880

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (0.3%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gentamicin (0.3%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Povidone-Iodine (5%)
Number of subjects: 0
Study: 7940651

Group type: EXPERIMENTAL
Intervention: Zung-12 administered in the morning
Number of subjects: 79

Group type: COMPARATOR
Intervention: Zung-12 administered in the afternoon
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Subjects with lower education
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Subjects scoring above the cutting point
Number of subjects: 79
Study: 2573679

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen, hypoxic cell radiosensitizers, modification of the oxygen‐unloading capacity of haemoglobin, hyperthermia, bio‐reductive drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypoxic cell radiosensitizers and other agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detailed analysis of individual tumours and patients' parameters
Number of subjects: 0
Study: 31669562

Group type: EXPERIMENTAL
Intervention: Clonidine 50 μg
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Clonidine 100 μg
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Clonidine (both doses)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 183
Study: 31839012

Group type: EXPERIMENTAL
Intervention: Nurture and Play (NaP) intervention group (n = 24)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 45
Study: 29046305

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 23
Study: 26454935

Group type: EXPERIMENTAL
Intervention: Navigation system developed by the authors (experimental group)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Image-free navigation system (control group)
Number of subjects: 106
Study: 24048291

Group type: EXPERIMENTAL
Intervention: Potassium supplementation (64 mmol potassium chloride for 6 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21182390

Group type: EXPERIMENTAL
Intervention: Group A - provided with reading material and images to draw and label surface anatomy.
Number of subjects: 144

Group type: COMPARATOR
Intervention: Group B - provided with the same reading material but answered short-answer questions.
Number of subjects: 144
Study: 20876406

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 17413115

Group type: EXPERIMENTAL
Intervention: Fortified khichdi
Number of subjects: 516

Group type: COMPARATOR
Intervention: Nonfortified khichdi
Number of subjects: 516
Study: 15620918

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting with white matter disease
Number of subjects: 104

Group type: COMPARATOR
Intervention: Spinal cord stimulation
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: No white matter disease
Number of subjects: 104
Study: 12380661

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl (50-100 microg/h)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 19
Study: 9928729

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (9900 micromol or 300,000 IU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7579846

Group type: COMPARATOR
Intervention: Conventional hypothermic CPB with rewarming
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Protocol where brain temperature is raised only to 34 degrees C at the time of separation from CPB
Number of subjects: 30
Study: 2292548

Group type: EXPERIMENTAL
Intervention: Intraperitoneal ciprofloxacin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intraperitoneal vancomycin and gentamicin (control)
Number of subjects: 40
Study: 6268498

Group type: EXPERIMENTAL
Intervention: Hametum Salbe
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control preparation
Number of subjects: 116
Study: 30651324

Group type: EXPERIMENTAL
Intervention: SYNB1020 (engineered E. coli Nissle 1917)
Number of subjects: 52
Study: 28422535

Group type: COMPARATOR
Intervention: Normal saline (NS) (0.9% sodium chloride)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ringer's acetate (RA)
Number of subjects: 20
Study: 25868467

Group type: EXPERIMENTAL
Intervention: no heat stress-euhydrated
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: heat stress-euhydrated
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: no heat stress-dehydrated
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: heat stress-dehydrated
Number of subjects: 12
Study: 22694918

Group type: EXPERIMENTAL
Intervention: Brief intervention consisting of a lecture and group work (1.5h)
Number of subjects: 1866

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 1866

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1866
Study: 21127898

Group type: EXPERIMENTAL
Intervention: Static squat with WBV
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Static squat without WBV (no-WBV)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No-exercise control (CON)
Number of subjects: 12
Study: 19441968

Group type: EXPERIMENTAL
Intervention: Filial Therapy and Kinder Training (play-based interventions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-control group
Number of subjects: 0
Study: 17868732

Group type: EXPERIMENTAL
Intervention: Sunitinib (50 mg daily for 4 weeks, followed by 2 weeks off drug per treatment cycle)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 106
Study: 15500630

Group type: EXPERIMENTAL
Intervention: Exposure to normal office dust at 136 microg/m3
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exposure to normal office dust at 390 microg/m3
Number of subjects: 24

Group type: COMPARATOR
Intervention: Clean air (control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Delayed effect on peak expiratory flow
Number of subjects: 24
Study: 11584378

Group type: EXPERIMENTAL
Intervention: Triple-antigen recombinant vaccine (20-microg dose)
Number of subjects: 925

Group type: COMPARATOR
Intervention: Single-antigen vaccine (S only)
Number of subjects: 925
Study: 9398000

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 7864561

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (400 mg, 2 daily infusions for 8 days)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37